Consolidated Financial Results (Earnings of FY2019/3)

Billions of yen
  FY2018/3
(Apr. - Mar. 2017)
FY2019/3
(Apr. - Mar. 2018)
Change
Amount %
Revenue 100.0% 2,433.4 100.0% 2,431.5 (1.9) (0.1)
Operating Income 5.1% 123.3 8.6% 209.8 86.5 +70.1
Income Before Income Taxes 8.1% 197.8 8.8% 212.8 15.0 +7.6
Net Income Attributable to
FUJIFILM Holdings
5.8% 140.7 5.7% 138.1 (2.6) (1.8)
Net Income Attributable to
FUJIFILM Holdings per Share
¥322.62 ¥326.81 ¥4.19
Exchange Rates: US$ ¥111 ¥111 -
Euro ¥130 ¥128 (¥2)

Revenue

In the fiscal year ended March 31, 2019, the Group recorded ¥2,431.5 billion in consolidated revenue (down 0.1% from the previous fiscal year), reflecting such factors as a sales decrease in the document business, although sales increased in the medical systems business, bio CDMO business, regenerative medicine business and electronic materials business.

Income

Operating income largely increased to ¥209.8 billion (up 70.1% from the previous fiscal year) due to improved profitability and positive impacts of structural reforms in the document business.

Consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

Archives (FY2005/3 - FY2018/3)